Acetic Acid

Acetic Acid

SCHEMBL6918388

C=C.C=C.CC(=O)O.CCCCOCCCC

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.54
ALDH1A1 P00352 1/20 0.52
CES2 O00748 2/20 0.50
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.45
RARB P10826 1/20 0.43
ATM Q13315 1/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7600113 1.00 TSHR (0.54) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL28723481 0.95 TSHR (0.59) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL9616198 0.95 TSHR (0.59) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL37245 0.95 TSHR (0.59) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL5480554 0.93 TSHR (0.60) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL14759095 0.92 TSHR (0.56) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL16761012 0.92 TSHR (0.56) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL29287060 0.92 TSHR (0.56) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL1996435 0.92 TSHR (0.56) TSHRALDH1A1CES2CYP3A4HPGD
Acetic Acid SCHEMBL4617603 0.92 TSHR (0.56) TSHRALDH1A1CES2CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024133631-A1 VETERINARY COMPOSITION COMPRISING OCLACITINIB KRKA, D.D., NOVO MESTO (SI) 2024-06-27 WO disclosed
US-20230414576-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS ZOETIS SERVICES LLC 2023-12-28 US disclosed
EP-4025209-A1 PALATABLE SOFT-CHEW Elanco US Inc. (US) 2022-07-13 EP disclosed
US-20210379023-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS ZOETIS LLC 2021-12-09 US disclosed
US-20210068425-A1 PALATABLE GRANULAR VETERINARY COMPOSITIONS BAYER HEALTHCARE LLC 2021-03-11 US disclosed
US-20210069104-A1 PALATABLE SOFT-CHEW BAYER HEALTHCARE LLC 2021-03-11 US disclosed
WO-2021046296-A1 PALATABLE SOFT-CHEW BAYER HEALTHCARE LLC (US) 2021-03-11 WO disclosed
US-20210051969-A1 RECOMBINANTLY EXPRESSED TASTE MODIFYING POLYPEPTIDES AND PREPARATIONS AND FORMULATIONS COMPRISING THE SAME OOBLI, INC. 2021-02-25 US disclosed
EP-2983712-B1 COMPOSITION OF MACROCYCLIC LACTONES, LEVAMISOLE, AN AMINO SUGAR AND AN ADDITIONAL ANTIPARASITIC AGENT ZOETIS SERVICES LLC (US) 2020-11-25 EP disclosed
WO-2019173541-A1 RECOMBINANTLY EXPRESSED TASTE MODIFYING POLYPEPTIDES AND PREPARATIONS AND FORMULATIONS COMPRISING THE SAME MIRACULEX, INC. (US) 2019-09-12 WO disclosed
US-20170354593-A1 PALATABLE CHEWABLE VETERINARY COMPOSITION ZOETIS SERVICES LLC 2017-12-14 US disclosed
EP-2999339-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS Zoetis Services LLC (US) 2016-03-30 EP disclosed
US-20160081986-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS ZOETIS SERVICES LLC (US) 2016-03-24 US disclosed
US-20160051524-A1 STABLE VETERINARY COMBINATION FORMULATIONS OF MACROCYCLIC LACTONES AND IMIDAZOTHIAZOLES ZOETIS SERVICES LLC (US) 2016-02-25 US disclosed
EP-2983712-A1 COMPOSITION OF MACROCYCLIC LACTONES, LEVAMISOLE, AN AMINO SUGAR AND AN ADDITIONAL ANTIPARASITIC AGENT Zoetis Services LLC (US) 2016-02-17 EP disclosed
WO-2014169092-A1 COMPOSITION OF MACROCYCLIC LACTONES, LEVAMISOLE, AN AMINO SUGAR AND AN ADDITIONAL ANTIPARASITIC AGENT ZOETIS LLC (US) 2014-10-16 WO disclosed
US-20040075802-A1 Sealant for liquid crystal display cell, composition for liquid crystal display cell sealant and liquid crystal display element MITSUI CHEMICALS, INC. (JP) 2004-04-22 US disclosed
US-6555187-B1 Mixture of specified physical properties of an epoxy resin, rubber-like polymer fine particles, inorganic filler, curing agent; use in single layer press hot bonding system, high productivity and humidity resistant MITSUI CHEMICALS, INC. (JP) 2003-04-29 US disclosed
EP-1153952-A1 SEALING AGENT FOR LIQUID-CRYSTAL DISPLAY CELL, COMPOSITION FOR SEALING AGENT FOR LIQUID-CRYSTAL DISPLAY CELL, AND LIQUID-CRYSTAL DISPLAY ELEMENT Mitsui Chemicals, Inc. (JP) 2001-11-14 EP disclosed
US-3960610-A Process for coating metals AMCHEM PRODUCTS, INC. (US) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230414576-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS ADRA1B, ADRA1A, ADRA2B TSHR 743/4885ALDH1A1 48/4885CES2 3031/4885
US-20210069104-A1 PALATABLE SOFT-CHEW TAS2R40, TAS2R45, TAS2R42 TSHR 3543/4885ALDH1A1 2225/4885CES2 1094/4885
US-20170354593-A1 PALATABLE CHEWABLE VETERINARY COMPOSITION PIGS, TAS2R31, TAS2R42 TSHR 3831/4885ALDH1A1 3413/4885CES2 3842/4885
US-20210379023-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS ADRA1B, ADRA1A, ADRA2B TSHR 743/4885ALDH1A1 48/4885CES2 3031/4885
US-20210068425-A1 PALATABLE GRANULAR VETERINARY COMPOSITIONS PIGS, VMA21, PGA5 TSHR 4348/4885ALDH1A1 3293/4885CES2 4788/4885
US-20160081986-A1 LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS ADRA1B, ADRA1A, ADRA2B TSHR 743/4885ALDH1A1 48/4885CES2 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.